Winning Combination

Having a combined regulatory and market access strategy is critical for a drug launch to be successful.

Marcus Deans, Mark A De Rosch and Emmanuelle Voisin

Emmanuelle Voisin CEO Voisin Consulting

Dr. Emmanuelle Voisin founded Voisin Consulting Life Sciences in 1997. She has 30 years’ experience in drug development. Her expertise lies in non-conventional development strategies, maximizing the use of regulatory mechanisms and innovative approaches to drug development, to bring innovative technologies to patients.

View Profile

Download the full Publication now